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Gender convergence in human survival and the 
postponement of death 
 
Abstract 
 
It has been a long accepted demographic maxim that females outlive males. Using data for England and 
Wales, we show that life expectancy at age 30 is converging and continuation of this long-term trend 
suggests it could reach parity in 2030.  Key among the reasons identified for the narrowing of the gap 
are differences in smoking prevalence between males and females which have narrowed considerably. 
Using data from 30 comparator countries gender differences in smoking prevalence are found to 
explain over 75% of the variance in the life expectancy gap, but other factors such as female 
emancipation and better health care are also considered.  The paper presents a model which considers 
differences in male and female longevity in greater detail using novel methods for analysing life tables. 
It considers the ages from which death is being postponed to the ages at which people now die; the 
relative speed at which these changes are taking place between genders; how the changes observed are 
affecting survival prospects at different ages up to 2030. It finds that as life expectancy continues to 
rise there is evidence for convergence in the oldest ages to which either gender will live. 
  
Key words: life expectancy gender gap smoking prevalence survival model 
convergence 
 
1.0 Introduction 
 
It has been a long accepted demographic maxim that females outlive males. However, 
when one examines the historical record for the last century the gap in life expectancy 
tends to vary but as part of a long term trend. For years at a time the gap appears to 
close, while other times it widens or remains the same.  
 
Sometimes the reasons are obvious and coincide with either wars or epidemics but at 
other times life expectancy drifts apart or narrows due to no obvious event. It would 
be hard to justify these differences on biological grounds since the gender gap varies 
so much and is different in each country and so is more likely to be societal in origin. 
 
Currently we are in a period in which overall life expectancy is increasing rapidly, 
with death being postponed to much older ages. Also apparent in a number of 
countries is a convergence in gender life expectancy which Trovato (2007) calls the 
‘emerging epidemiological feature of post-industrial societies’ (see also Trovato, 
1996, 2003 and 2006, Tuljapurkar et al 2000). 
 
Convergence has become a well entrenched trend over recent decades in England and 
Wales as male life expectancy catches up with that of females. To this end, we 
develop a model which enables us to discern differences in survival by age and gender 
and which allow us to project the consequences of this trend in future years in order to 
understand the processes in detail and how they affect each gender separately. 
  
The economic and practical ramifications of the postponement of death over a long 
period are considerable. The extra years lived into a person’s 80s and beyond will 
require assets to be decumulated over more years putting a strain on personal 
finances. In addition, both the state and families as well as individuals will experience 
increases in health and social care costs and there may not be enough caregivers to 
look after all older people in the future. All of these have the possibility of acting as a 
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break on further advances in life expectancy itself and therefore confound the trends 
currently underway (Thatcher et al, 2008).  
 
Taking a more positive view, males will be enabled to work for longer in reasonable 
health and be expected to live for almost as long as their partners (after taking account 
of the typical age difference upon union), whilst cohabitation itself is a factor in 
reducing mortality (Cheung, 2000, Karlsson et al, 2009).   
 
In this paper, we address two sets of issues: firstly, how quickly is life expectancy 
increasing and why is it converging, including the prospect it will continue to increase 
at the same pace. Secondly, we consider whether convergence is benefitting all ages 
or just some, and the degree to which these benefits vary by gender. In the next 
section, we deal with the first of these questions, by reviewing the trends and 
comparing England and Wales with other countries.  
 
As we shall argue, many of these advances that are described are due to the adoption 
of healthier lifestyles over a period, but key among these is the huge reduction in the 
prevalence of smoking since 1948. To assist with the second set of issues we develop 
a model of survival and apply it to the England and Wales population. Section 3 
describes the model; Section 4 fits the model to data and Section 5 analyses the 
results. A concluding section then follows.  
 
2.0 Gender gap in life expectancy at age 30 
 
Life expectancy is defined as the average number of years an individual is expected to 
live based on mortality rates at different ages. An increase in life span may affect 
individual age cohorts differently, resulting in a variety of postponement of death 
patterns and trends over time. 
 
A distinction can be drawn between pre- and post 30 years of age. Before age 30 there 
are currently more gender related differences in male and female mortality than post 
30. At birth, more males die before age one than females although with reductions in 
infant mortality of 75% since 1970 in England and Wales this difference is less 
noticeable than previously.  
 
There is also a marked increase in male mortality between 16 and 30 years but much 
less so for females. In 2009 the male ‘accident hump’ had reduced slightly and now 
there is no discernible female hump at all. Reasons for the hump include the fact that 
men tend to be involved in riskier activities such as dangerous sports, tend to be more 
prone to road and other accidents, and are more likely to commit suicide. 
  
By analysing expectation of life at 30, these differences are largely removed. This 
allows us to study changes in the patterns of deaths for people in their wealth- 
creating and family rearing years. In doing so, we also avoid the complication of 
separating out the influences of reductions in childhood mortality and other factors.  
 
We select England and Wales as our exemplar because it is a particularly interesting 
case study and, as we shall see, a potential lesson to other countries where 
convergence is less evident. Figure 1 shows how life expectancy at 30 has steadily 
progressed from 1950 to 2009 for both genders.   
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By 2009 female life expectancy stood at 53.2 years and male life expectancy at 49.4 
years, a difference of 3.8 years. This compares with a gap of 5.7 years in 1970 when it 
was at a maximum. The trends in life expectancy are very accurately described by a 
second order polynomial equation, shown in Figure 1 as dotted lines.  
 
Based on this, male and female life expectancy is forecast to converge at 57.1 years 
by 2030.  That is not say that the convergence will definitely occur but the trends are 
well entrenched. However, it is necessary to investigate the mechanisms that underpin 
such a prediction and its robustness. 
 
 
Figure 1: Trends in life expectancy at age 30 in England and Wales by gender  
 
If England and Wales is compared with France, Japan and Sweden, it turns out that 
England and Wales is the only one in which male life expectancy has increased by 
more than female life expectancy in the period 1950 to 2009 (8.9 years versus 8.6 
years) and in where female life expectancy has increased least. 
 
Table 1 shows that the longest lived males are Swedish (51.4 years) and the longest 
lived females are Japanese (57.9 years). Section B of Table 1 shows that the gender 
gap in England and Wales was 3.8 years and therefore comparable with Sweden at 3.7 
years and much lower than in either France or Japan. As a percentage of male life 
expectancy only Sweden had a slightly lower gap than England and Wales at 3.7% 
 
Section C of Table 1 shows that in England and Wales the gap reached a maximum of 
5.7 years in 1969 or 8.3% of male life expectancy. This compares with 7.5 years in 
France or 16.4% of male life expectancy reached in 1992, which is the biggest 
divergence recorded among this group of countries. In Sweden, the peak came in 
1983 when the gap was 5.6 years and equivalent to10.9% of male life expectancy.  
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Of the four countries, Japan is the odd country out. Here the gender gap has been 
mainly growing in size since 1950 and reached a peak at 6.7 years or 13.3% of male 
life expectancy in 2003, the highest of any of the countries shown. Part of the reason 
for this is that female life expectancy in Japan has grown faster than elsewhere, but 
also that the rate of growth in male life expectancy has lagged behind.  
 
It is instructive to investigate how the gender gap in life expectancy has changed over 
the longer term. Although one would expect the gap to be smaller because life 
expectancy was much lower in earlier decades, it was also smaller as a percentage of 
male life expectancy in the early part of last century as is apparent in section D of 
Table 1 (data for Japan are unavailable before 1947).  
 
 
Life expectancy at 30 (yrs) 
England 
and 
Wales France Japan Sweden 
A Females 2009 53.2 55.1 57.9 55.1 
 
Males 2009 49.4 48.8 51.4 51.4 
      B Gender  gap (yrs) 3.8 6.3 6.5 3.7 
 
Gap as % of male life expectancy 7.7 12.9 12.6 7.2 
 
improvement relative  to  (C) (years) -1.9 -1.2 0 -1.9 
      C Maximum  gender gap since 1950 (years) 5.7 7.5 6.7 5.6 
 
as % of male life expectancy 13.3 16.4 13.3 10.9 
 
year in which occurred 1969 1987 2003 1983 
      D Minimum  gender  gap since 1900 (years) 2.5 2.6 3.1 0.5 
 
as % of male life expectancy 7.1 7.2 7.8 1.3 
 
year in which occurred 1909 1903 1951
(1)
 1922 
 
Table 1:  Comparative life expectancy at age thirty in selected countries by gender 
(source: HMD).(Note (1): Japanese data unavailable before 1947) 
 
In England and Wales and France a minimum gap was attained in 1909 and 1903 
respectively. In Sweden it reached a minimum in 1922, after falling gradually for 
most of the previous century, of just 0.5 years or 1.9% of male life expectancy. This 
marks the year when the gender gap was at its narrowest in any of the four countries.  
The Swedish case lends weight to the argument that there are no fundamental 
biological differences between male and female life expectancy, but that the factors 
responsible for the gap are primarily societal and gender-centric (Trovato, 1996). 
 
2.1 Why is death being postponed? 
 
In order to understand these trends in more detail we need to ask why death is being 
postponed more so in the case of males and why it is happening at different rates in 
some countries.  In England and Wales, the underlying gender gap that emerged and 
which peaked in 1969 was the culmination of a number of effects including the 
increased prevalence of smoking over a period, cancer, heart disease etc. among men 
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born around the turn of the century and who especially developed smoking habits 
from the 1920s onward.  
 
The following points are noteworthy: 
 
 About one in six of all deaths in England and Wales are smoking related.  Of 
these, about 60% are among men and 40% women. Smoking exacts a large 
death toll in the form of chronic obstructive lung disease, and ischemic heart 
disease among the over 65s, whilst death from lung cancer is attributable to 
smoking in about 85% of cases. 
 
 Since 1948, 82% of males smoked some form of tobacco and 65% smoked 
cigarettes. Today only 21% smoke cigarettes
1
.  Females took up the smoking 
habit later than males peaking at about 40% before declining to 20%. As 
smoking among women increased, there were accompanying increases in 
female rates of lung cancer and other smoking related diseases (e.g. see 
Pampel, 2006, 2003, 2002).  
 
 The levels of smoking related mortality depend on tobacco consumption, 
quitting rates and lifetime exposure. It is not inconsistent for example for 
mortality rates to continue rising whilst smoking prevalence is falling and so 
the benefits of smoking cessation tend to percolate gradually at least initially 
(Murphy and Di Cesare, 2012). 
 
 According to Doll et al (2004), a ceased smoker at age 30 could expect to live 
10 years and at 60 three years extra. Crudely speaking, if the remaining 20% 
of smokers ceased smoking then this would eventually add another two years 
to the life expectancy of the whole population after which time the full 
dividend from smoking cessation will be approached. 
 
 Coronary heart disease (CHD) mortality, itself smoking related, has been 
declining since the 1960s. Unal et al (2004) found that 58% of the coronary 
heart disease mortality decrease in England and Wales between 1981 and 2000 
was attributable to reductions in major risk factors, principally smoking, blood 
pressure and cholesterol. In addition, there are now effective treatments for 
heart disease such as coronary artery surgery, angioplasty, statins, and other 
medications (Laatikainen et al, 2005). 
 
 Trovato (2005), using data from Canada, found that in 1971, 41% of the 
difference in male an female life expectancy at birth could be accounted for by 
heart disease, 19.7% by accidents, violence and suicide and 9.5% by lung 
cancer. Based on data from 2000, he found that the gap had narrowed by two 
years in which time the contribution of heart disease had fallen to 27.5% and 
accident, violence and suicide to 11.5%. 
 
The relatively small gender gap in life expectancy in Sweden is of particular interest. 
While smoking rates among Swedish women have been consistent with those of other 
European countries (a fact reflected in comparable lung cancer rates), smoking rates 
                                                 
1
 Source: Cancer research UK 
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among men in Sweden have always been lower than those of their European 
counterparts. Sweden’s neutrality in both world wars is a factor in the low take up of 
smoking among Swedish males; however, a second reason is the traditional 
consumption of ‘snus’, a moist powder form of tobacco which is placed under the lip 
and not smoked. 
 
Japan is an exception where smoking is still relatively widespread among males; 
statistics show Japanese men smoke at one of the highest rates in the world at 36% but 
only 12.1% of Japanese women do so. In France, 36% of males also smoke but 
prevalence in women is over twice the rate of Japanese females. More generally, we 
find that the difference in smoking prevalence between genders is a good indicator of 
gaps in life expectancy. Using data from 37 countries (see also Annex B), we 
ascertained for example that 75% of the variation in the gap in life expectancy at age 
30 could be explained in this way confirming similar results obtained by Trovato 
(2005).
2
  
 
The greatest gender differences in life expectancy and smoking prevalence occur in 
Russia and east European countries and the least differences in west European 
countries, Australia, Canada and New Zealand. However, this correlation is truer for 
more developed countries with long established patterns of tobacco consumption. In 
less developed countries, the gender gap is less because life is shorter and death tends 
to be from non-smoking related causes. Clearly, there will come a time when smoking 
will take a similar toll on human life in rapidly developing regions such as China, 
India, Middle Eastern countries and South America, as more people reach the age at 
which smoking related diseases make an impact. 
 
2.2 Other factors 
 
Not all of the gender gap can be explained by differences in smoking prevalence 
although smoking is often implicated indirectly.  Other factors are important and may 
be correlated with people who smoke but they are not as well supported by 
comprehensive data. A distinction can be drawn between those affecting both genders 
and those that are gender specific. Hence, working in hazardous industries affects 
males more than females but infectious diseases, cold winters, hot summers, 
economic depressions, urban smog and so on are largely gender neutral, especially if 
there is a pre-existing health condition. 
 
Since the 1980s the UK has undergone a significant industrial transformation with the 
numbers employed in manufacturing and mining falling substantially. Employment in 
the coal mining industry, strongly associated with lung disease, has fallen from a peak 
of 1.2m in 1920, 0.3m in 1970 to 5,000 today. There are also factors causing female 
life expectancy to rise more slowly. An example is increasing female adoption of 
unhealthier male behaviours, increases in smoking being a prime example (Pampel, 
2005 a and b).  Trovato (2005), for example, finds that while increased female labour 
force participation is not significantly associated with female smoking, it is inversely 
correlated with gender differences in life expectancy.  
 
                                                 
2
 See WHO report on the global tobacco epidemic, 2011: warning about the dangers of tobacco. 
http://www.who.int/tobacco/global_report/2011/en/index.html/Human  and The Human Mortality 
Database, http://www.mortality.org/ 
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A more contemporary phenomenon and threat to life expectancy is the rise in obesity. 
According to Eurostat (2011), 22% of males in the UK were obese and 23.9% of 
women.
3
 Obese people are more likely to suffer from diabetes which in turn can lead 
to other health complications and premature death (Hippisley-Cox et al, 2010).  
Among the morbidly obese (BMI levels of 40+), an individual could lose between 5.6 
and 10.9 years of future life at age 30 if they remain obese (Mayhew et al, 2009).
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Although obesity in women does not affect life expectancy as much as it does in men, 
it has the potential to limit life expectancy gains among women if obesity grows at a 
faster rate. 
  
It has been argued that the root causes of disparities in life expectancy are health 
inequalities, most of which are largely preventable (Marmot, 2011
5
). Smoking, 
obesity, alcohol abuse and other factors are strongly associated with disparities in 
wealth and income. For example, Marmot shows that people living in the poorest 
neighbourhoods in England will on average die seven years earlier than people living 
in the richest neighbourhoods. The causes are complex, but appear to impact more on 
men than women due to differences in their health behaviours. Mayhew (2010, 2011), 
for example, found a gender gap of up to 14 years among male adults who are 
economically inactive, have low educational status, live alone and who smoke as 
compared with the longest lived lives. 
 
2.3 Future prospects  
 
In looking forward the question arising is whether the gender gap will continue to 
narrow at current rates and for life expectancy to converge by 2030. There do not 
appear to be any fundamental biological reasons or barriers why the extra level of life 
expectancy required is unattainable. Already Japanese females are living to the age 
forecast for England and Wales in 2030 i.e. 57 years and so we know that extra years 
are achievable. More fundamentally, Oeppen and Vaupel (2002) find that there has 
been an unbroken linear rise in life expectancy of about three months a year for at 
least 150 years and so increases post 2030 are also probable.  
 
The main barriers, if any, are societal in origin. Vaupel (2010), summarising reasons 
for increases in life expectancy, finds that only about 25% of the variation in adult life 
spans is attributable to genetic differences. As long as there is continued access to 
health care, etc. life expectancy should continue to improve, he suggests, especially if 
coupled with healthier lifestyles, exercise and diet. Karlsson et al (2010), studying the 
effects of a reduction in income inequality would have on life expectancy, found that 
reducing the UK income inequalities to the levels recorded in Sweden would increase 
                                                 
3
 Eurostat, 2011. Overweight and obesity - BMI statistics. 
http://epp.eurostat.ec.europa.eu/statistics_explained/index.php/Overweight_and_obesity_-
_BMI_statistics 
4
 For various reasons there is an increasing preference for using waist to height ratio (WHtR) instead of 
BMI for measuring obesity.  For example WHtR is easier to measure and provides better visual 
representation. A WHtR of 0.5 (i.e. height is twice waist) is considered optimal in males and equivalent 
to a BMI value of 25.  In females the equivalent is a WHtR of 0.43. It is estimated that a BMI of 30 
(borderline obese) equates to a WHtR of 0.53 in women and 0.60 in men. 
5
 Fair Society, Healthy Lives – the report of the Marmot review (2011) 
http://webarchive.nationalarchives.gov.uk/+/www.dh.gov.uk/en/Publichealth/Healthinequalities/DH_0
94770 
9 
 
life expectancy by 0.16 years and eliminating inequalities altogether would achieve 
0.41 years.  
 
As disparities in life expectancy reduce, death should gradually be concentrating into 
fewer years at older age. If true, this means that gender differences in survival will 
also gradually disappear subject to the caveats set out above. These processes are 
collectively known as the compression of mortality or sometimes as 
‘rectangularisation of the survival curve’, about which there is a substantial literature, 
e.g. see Robine (2008), Thatcher et al (2008), Bongaarts (2005), Kannisto (2000), 
Wilmoth and Horiuchi (1999), and Fries (1980).  
 
There is debate however about whether rectangularisation is actually occurring in the 
way envisaged (Canudas-Romo, 2008). In results presented here, we find that patterns 
in survival are a more complex mixture of effects depending on age, gender and 
period. We tackle this issue by developing a simple stylised model of survival of 
which there are three basic types: the divergent, parallel and convergent cases. In the 
divergent case, health inequalities widen and life expectancy gains are shared 
unequally; in the parallel case gains are shared equally but health inequalities are 
unchanged; in the convergent case, based on rectangularisation of the survival curve, 
gains are also shared unequally but health inequalities are reduced.  
 
2.4   Outline of rest of paper 
 
Thus far we have used life expectancy as a yardstick for measuring the differences 
between genders. However, life expectancy is a broad measure that does not take 
account of variations in the mortality experience at various ages. For example, a 
population with a constant death rate from birth in which everybody is dead by age 
100 would have the same life expectancy as a population that all died on their 50
th
 
birthday. In order to understand what lies behind the finding that male and female life 
expectancy is converging we therefore need to go into considerably more detail.  
 
There are three issues to consider: 
 
1. How changes in life expectancy are affecting survival prospects at different 
ages over time, for example the relative chances of a male or female reaching 
very old ages both in the past and future, and the parts of the survival 
distribution that are benefitting most.  
 
2. Changes in the mean and modal age of death to ascertain whether, as well as a 
convergence in life expectancy, there is a trend towards greater concentration 
of death within a narrower age range and if this is different for males and 
females. 
 
3. By comparing different periods, to identify the ages from which death is being 
postponed to the ages at which people now die, including the relative speed at 
which these changes are taking place and how to interpret the patterns that are 
the result. 
 
We start by describing a simple, stylised survival model, which we use to show how 
different postponement processes lead to characteristic mortality patterns which can 
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be compared with patterns found in reality and enable us to address these issues.  We 
use this model to understand the processes by which life expectancy and survival are 
interrelated. 
 
To apply the model in practice, we exploit the empirical relationship between life 
expectancy and the probability of survival to a given age. We then use this 
relationship to establish age specific survival probability in some future year to which 
we then fit a Gompertz-Makeham function (e.g. see Olshansky and Carnes 1977 or 
Forfar and Smith 1987).  
 
Using life tables for England and Wales, we extend our previously developed 
approach (Mayhew and Smith, 2011 and 2012). From this we derive full single year 
life tables which we then use to extract the current and future predicted number of 
deaths by year and gender. We then compare differences in age of death at ten year 
intervals from 1950 to 2030. The results appear as waves which are broadly sinusoidal 
in shape. From these waves we derive measures such as amplitude and wave length to 
compare differences in the pattern of change between males and females.  
 
The results show substantially different gender patterns and confirm that the 
momentum for improvements in life expectancy has switched from younger to older 
ages and that men are outperforming women in some sections of the survival 
distribution and under performing in others. In the next section we set out a stylised 
and simplified version of the model. In Section 4 we fit the model to data from 
England and Wales, in Section 5 we set out results and in Section 6 we discuss the 
findings and conclusions. 
 
3.0 A simplified model of survival and death postponement 
 
Mathematically the survival curve )(xS denotes the probability of surviving to age x , 
whereas )(xe  defines life expectancy at age x . We initially develop our ideas into the 
form of a simple, stylized model in order to gain insights into the processes linking 
the probability of survival, death and life expectancy. This allows us to derive a basic 
relationship between the survivorship and the postponement of death. 
 
Imagine a stationary population in which there are a constant number of births and 
deaths and no migration and that is subjected to the same mortality regime each year. 
Consider Figure 2(a), which shows the survival curves ABC and AED for 
hypothetical populations at two points in time, 
1t and 2t .  
 
The )(xS  curve may be compared to a life table which is based on an imaginary 
population usually of 100,000 people. This means that 1000 deaths represent 1% of 
all deaths. Deaths at each age are recorded and subtracted from the remaining lives. 
The life table continues until an age is reached by which all 100,000 are dead 
corresponding to 2x (point C) or 
'
2x (point D) depending on the time period.  
 
We define the point 
1x  in Figure 2(a) as the original onset of mortality, the age at 
which death begins, which can range from zero upwards. For simplicity, we assume 
there are no deaths before this age. We call the point where BC cuts the age axis 
2x  
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or the maximum age to which anyone lives, and so life expectancy is originally given 
by .2/)( 21 xx                           
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2: Simplified model of survivorship and death 
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Both 1x and 2x  are somewhat fuzzy quantities in the real world. In developed 
countries we could assume the onset of mortality ( 1x ) occurs from around 50 years 
onward.  
 
The exact age is imprecise but may be defined by reference to particular percentiles of 
deceased, for example, 10%. The same applies to maximum age at death in which it 
may be more appropriate to assume that 2x  is the age of death of the 90th percentile.  
 
However, our purpose is to use 1x  and 2x  as conceptually useful devices to anchor 
and compare distributions and mortality processes, rather than to determine them 
empirically.  
 
Now imagine the age distribution of the population at another point in time, 2t . In 
Figure 2(a), we see that 1x  has shifted to the right to
'
1x , while 2x  has advanced to 
'
2x  
(point D). Life expectancy is now  .2/)(
'
2
'
1 xx  
 
In other words, the onset of mortality and maximum age has increased, and as a result 
many more people live to older ages. In this example, we see that 1x  and 2x  have 
advanced by slightly different amounts, such that the mortality gradient in 2t  is 
steeper than in 1t  and so more die at each age after 
'
1x .  
 
Figure 2(b) shows the pattern of deaths in 1t  and 2t . The later commencement of 
mortality in 2t  has caused a shift in the ages of death to the right, but because the 
mortality gradient is steeper the deaths are bunched into a shorter age range. 
 
In Figure 2(c), we subtract deaths by age in 2t  from 1t  in order to show how death has 
been effectively postponed between each snapshot.  It shows that before point P there 
were fewer deaths at 2t  than at 1t  but more after point P. The effect is to create a 
wave or pulse with a fall in death prior to age P and an increase post P. 
 
We define P as the pivot point, the heights (c-d) of the peak and trough as the 
amplitude, and the distance (a-b) the peak-to-trough age range. These quantities are 
identified by arrows with a diagonal arrow indicating the postponement effect which 
the stylised model is trying to capture.  
 
Note also that since we fix at the outset the maximum deaths occurring in any one 
year to 100,000, it follows that the total deaths below the horizontal axis defined by 
zero, i.e. deaths postponed, must equal the total deaths above.  As we shall see later, 
using actual life tables the waves are smooth curves and so there is no difficulty in 
defining a or b accurately. 
 
Let us assume that at time 
1t  lives aged below 1x  have the mortality rates that are 
assumed by '
1x  and 
'
2x  whereas lives aged 1x  and over at 1t  still remain with the old 
mortality rate. Figure 2(d) shows the time taken for the population of people with the 
improved mortality rates to reach the new steady state. We define this as the transition 
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period in which the population that has become healthier adjusts to its new steady 
state. It shows the expected change in the number of deaths between periods which, 
for the purposes of the stylised model, is assumed to be an incremental process that 
progresses at an even rate year on year. In other words, we assume a process in which 
mortality affects future cohorts and not cohorts already aged 
1x or over.  
 
Consider the simplest case in which 
1
'
1 xx  at 1t  and 2t . 
 
For 
1t x   i.e. before these new ‘healthier’ lives reach 1x  
 
Death rate 
2 1
2 1
x
x
l
x x l
x x
 
in which xl is the number of survivors to age x . This is intuitive as we start with a 
stable population and if 
xl  people are born then the same number must die. 
 
For
1 2x t x  i.e. when the new ‘healthier’ lives reach 1x and die at the new lower rate 
but we still have some older lives dying at the original rate 
 
Death rate 
2 1
2 1 2 1
x xl lx t t x
x x x x
 
 
The first term involves the older lives who die at the original rate.  As t increases this 
number reduces (as the population with original mortality rates dies out).  The second 
term involves the newer lives dying at the newer, lower rate.  A more general case can 
be constructed involving changes to both 
1x and 2x but is slightly more complicated.  
 
The main result of this process is that death rates fall initially as the new healthier 
cohort ages and then once the whole population is part of this cohort rates climb again 
to previous levels. The area pqrs represents the total deaths avoided between  
1t  and 
2t  and is equivalent to the area BECD in Figure 2(a).  
 
3.1 Postponement of death in selected cases 
 
Averting deaths may either increase or reduce life disparity between ages of deaths 
depending on changes in shape of the survival curve (Zhang and Vaupel, 2009). Our 
principal interest lies in changes to the distribution of deaths over the age register, for 
example whether they are bunched or spread out.  
 
As well as the specific example in Figure 2, other variants can be constructed 
depending on assumed changes to 
1x  and 2x . Of these, five particular cases can be 
conveniently identified which help us to identify and interpret real world patterns.  
 
The first three cases, which were described in detail by Mayhew and Smith (2011), 
are known as the divergent, parallel and convergent cases. Cases four and five, termed 
regressive cases, are aberrant variants but are nevertheless possible in specific 
circumstances. 
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Figure 3 lists each case. An adjacent diagram shows the change in the pattern of 
deaths between time periods. Postponed deaths are represented below the line and are 
of course exactly balanced by deaths above the line.  
 
 
 
 
 
1. Divergent case: 
 
2
'
21
'
1 xxandxx
 
 
 
 
 
2. Parallel case: 
 
)()( 2
'
21
'
1 xxxx  
 
 
 
3. Convergent case: 
 
2
'
21
'
1 xxandxx  
 
 
 
4. Regressive case (i) 
 
2
'
21
'
12
'
2,1
'
1 ,0,0 xxxxxxxx  
 
 
 
5. Regressive case (ii) 
 
2
'
21
'
12
'
2,1
'
1 ,0,0 xxxxxxxx  
 
 
 
 
 
Figure 3: Postponement of death in selected cases. The graphs to the right show the 
postponement patterns consequent upon the parameter changes to the left 
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In the divergent case, the age of onset of mortality 
1x does not change but the 
maximum age of death progresses from 
2x to 
'
2x . Deaths are postponed to older ages 
around a unique pivot point and life expectancy benefits by 2/)( 2
'
2 xx  years.  The 
amplitude of the wave above the line is lower than that below the line, but also the 
width of the trough is narrower than the peak because death is being postponed from a 
narrow to an extended age band. 
 
In the parallel case, the age of onset increases by exactly the same number of years as 
the maximum age of death. Everyone benefits similarly as life expectancy increases 
by )( 2
'
2 xx . Postponed deaths form a peak below the line and are matched in shape 
and amplitude by deaths above the line separated by a gap of )( 1
'
1 xx  years, so the 
width of the trough and the peak and also the amplitudes are the same. 
 
In the convergent cases, the age of onset of death progresses but the age of maximum 
deaths is fixed. The survival curve now becomes more rectangular in shape leading to 
greater equality in life span and hence a demonstration of the rectangularisation 
hypothesis. Deaths bunch and increase in amplitude above the line and are separated 
from deaths below the line by a unique pivot point. In this case, the width of the 
trough is wider than the peak but the amplitude of the peak is greater. In this case, life 
expectancy increases by 2/)( 1
'
1 xx  years as with the divergent case. 
 
The two regressive cases describe situations in which there is either a reduction in the 
age of onset of death balanced by an increase in the maximum age of deaths or an 
increase in the age of onset of death balanced by a fall in the age of maximum death. 
In neither case is there necessarily any change in life expectancy. In such cases, we 
would expect to see either a double peak in the number of deaths or a double dip. This 
is caused by one part of the age distribution experiencing an improvement in mortality 
and in the other part deterioration.   
 
The cases are unusual but not impossible and one could speculate specific scenarios 
that might generate such patterns. Examples could include an epidemic affecting 
younger age groups or an upsurge in smoking prevalence, a significant increase in 
obesity in people of young to middle age leading to earlier death, or simply the result 
of a slow process of change over time relating to general increases or decreases in 
health inequalities. 
 
4.0 Fitting the model 
 
The identification of patterns of postponement in deaths is split into two parts. In the 
next section, we fit the Gompertz-Makeham function to life tables extracted from the 
Human Mortality Database (HMD). We fit a mathematical function rather than use 
the actual life tables because we wish to extrapolate them so as to identify any future 
trends.  
 
We do so by analysing changes in the pattern of deaths at 10 year intervals in both 
males and females and interpreting the findings with reference to patterns identified in 
the stylised model. By projecting the model we are able to suggest which of the 
stylised variants appear to given the best explanation of underlying processes. 
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To create the life tables required to calibrate the model needed to predict survival in 
future years and to characterise patterns or trends in postponement, we adopt the two 
stage process described in Mayhew and Smith (2012). 
 
In the first stage, using actual data based on the Human Mortality Database (HMD) 
for each calendar year from 1950 to 2009, we calculate the expected future lifetime 
and the percentiles of people that have survived in 1% steps.  
 
For each calendar year and every percentile, the results are tabulated in a spreadsheet 
with life expectancy in the first column and percentile survival ages in subsequent 
columns.  
 
We then fit linear regressions for each percentile to the resulting array of points using 
an equation of the following form in which x , the age at death, is the dependent 
variable:  
 
pppp uex 30  
 
where 
px  is the age of death of the population surviving to the p
th
 percentile 
p
,
p
 are the regression parameters of the pth percentile 
30e  is the expected future life expectancy at age 30 
pu is a random error term 
 
Table 2 sets out the fitted regression parameters for both males and females for a 
selected range of percentile survivorship. So for example for the male 70
th
 survival 
percentile, the value 70 = 19.8159 and β70 = 1.1274.  
 
If life expectancy at 30 is assumed to be 50 years then the predicted age to which 70 
per cent of the male population survives (or 30% die)  is 76.2 years [i.e. 19.8159 
+1.1274 50]. The equivalent value for females is 23.8491+1.0385 50 or 75.8 
years.  
 
Table 2 shows that the goodness of fit statistic, or coefficient of determination R-
squared, is always greater than 0.98 between the 1
st
 and 90
th
 percentiles suggesting 
that a high degree of accuracy is possible throughout the percentile range. Figure 4 
shows the results for males based on the 99
th
, 95
th
, 90
th
, 80
th
 …… 10th, 5th, and 1st 
survival percentiles including the fitted regression lines.   
 
In 1950, the beginning of the time window, future life expectancy at age 30 was 40.5 
years (denoted by hatched line A); in 2009 it was 49.4 years (hatched line B), a 
difference of 8.9 years over a 59 year period.  If we follow each hatched line from the 
bottom of the chart upwards until they cross the 50
th
 percentile (i.e. median life 
expectancy), we surmise that 50% of those turning 30 in 2009 could expect to live to 
age 82, as compared with an age of 72 for those turning 30 in 1952. 
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Male 
  
Female 
  percentile 
(th) p
 
p
 2R  p  p  2R  
99 26.7993 0.2623 0.4977 -1.4470 0.8794 0.9174 
95 19.1094 0.7318 0.9362 -1.0879 1.1521 0.9833 
90 16.4518 0.9367 0.9825 6.9702 1.1335 0.9894 
80 17.1963 1.0776 0.9977 17.4051 1.0755 0.9881 
70 19.8159 1.1274 0.9992 23.8491 1.0385 0.9930 
60 23.1957 1.1213 0.9987 27.8809 1.0268 0.9975 
50 27.3860 1.0950 0.9976 31.3071 1.0159 0.9994 
40 31.3516 1.0688 0.9973 34.7070 0.9999 0.9993 
30 35.8936 1.0296 0.9971 38.5608 0.9733 0.9983 
20 41.0291 0.9826 0.9972 42.4869 0.9487 0.9960 
10 47.1910 0.9303 0.9965 48.3621 0.8986 0.9907 
5 51.7976 0.8912 0.9935 53.2636 0.8518 0.9861 
1 59.5101 0.8280 0.9816 61.3460 0.7785 0.9740 
 
Table 2: Fitted regression parameters to data from the HMD (1950-2008) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4: Male life table survival percentiles as a function of life expectancy at 30 
England and Wales 
 
This table of parameters is primarily for use in fitting the survival function (see next 
section) but it also has a direct interpretation. The slope parameter p  represents the 
change in age of death for each one year improvement in life expectancy for a given 
percentile of the population.  If it is greater than one, it means that this percentile 
gains more than one year of life for each added year of life expectancy of the 
population.  Similarly, when p  is less than one, the percentile gains are less than one 
year of life for each added year of life expectancy.   
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Three cases can be recognised: (a) divergent, (b) parallel and (c) convergent. As 
Annex A explains, if values of p  are initially less than one and increase to above 
one as we move down the table, the corresponding stylised survival distribution is the 
divergent case. This means that higher percentiles are not benefitting from general 
increases in life expectancy as much as lower percentiles. If slope values are equal to 
one then the parallel case is indicated in which all ages benefit equally from increases 
in life expectancy. If values are initially above one and then fall to below one, the 
‘convergent’ case is indicated, in which case the trend points to a maximum age of 
attainment to which percentiles converge (i.e. rectangularisation).
 
 
 
From Table 2 we observe that the trends in the value of p  
do not fall exactly into 
any of the three cases. Overall the range of values appears to come closest in 
definition to the parallel case since a clear majority of values are close to one; 
however, the top and bottom of the distribution indicate contrary trends. Figure 5 
plots values of p  from 0% to 100% of deaths for males and females (or equivalently 
100% to 0 % survival). It has been sub-divided into sections depending on whether 
p  
is less or greater than one and whether p  is increasing or decreasing.  
 
If we take males first, p   increases in the range from 0% to 32% of deaths 
whereupon it reaches a maximum value at point D (age 76 in 2009). From this point 
onwards it turns from being a divergent pattern to being gently convergent suggesting 
a possible eventual limit to life span.  Up to point C, when p  equals exactly one, 
equating to the 13
th
 percentile (or people dying age 65 in 2009), males are benefitting 
less from general improvements in life expectancy. From point C to F, p  is greater 
than one and so this percentile range (age 65 to 92 in 2009) is benefitting most from 
general increases in life expectancy, for some lives by as much as 12%. Beyond point 
F, the 76
th
 percentile, p  falls below one and so males are benefitting less. 
  
In the female case, p   
increases as far as the 6
th
 percentile of deaths at point A (age 
61 in 2009), whereupon it reaches a maximum value.  From this point onward, it turns 
from being a strongly divergent pattern into being gently convergent.  Up to point A 
(age 51 in 2009) when p  equals exactly one, females are benefitting less from 
general improvements in life expectancy. Between points A and C, p  becomes 
greater than one and so this percentile range is benefitting most from general 
improvements in survival  – that is those dying between ages 51 and 88 in 2009. 
Beyond point E, p  falls to below one, and so, just as for males, the oldest lived 
females are benefitting less. 
 
In summary, up to point C males are benefiting less and survival is divergent; from C 
to D males are benefitting more and survival is still divergent; from D to F males are 
benefitting more and survival is convergent; and from D onwards males are 
benefitting less and converging. The pattern for females is somewhat different. Up to 
point A females are benefitting less and survival is divergent; from A to C females are 
benefitting more and survival is convergent; and from C onwards they are benefitting 
less and survival is convergent. 
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Hence convergence, albeit at a gentle rate of change, is occurring for 94% of the 
female percentile range as compared with 68% of the percentile range in the case of 
males. So we can say that females are converging more than males but the trend is for 
males to outlive females at the oldest ages. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5: Variations in survival parameter p  for the males and females that are 
dead
       
 
4.1 Calibrating the survival function 
 
 
A life table demands that the results be in the form of the proportion of people 
surviving to age x in strict one year intervals rather than surviving to a given 
percentile, and so we need a method of converting the results from percentiles into 
single year units.  
 
Following the method described in Mayhew and Smith (2011), we make use of the 
Gompertz-Makeham equation, which is a well-known and often used highly flexible 
function for fitting human survival curves (for historical review see Olshanksy and 
Carnes 1977).  
 
This states that the death rate is the sum of an age-dependent component (named after 
Gompertz 1825), which increases exponentially with age, and an age-independent 
component (named after Makeham, 1860).   
 
Using standard notation, the function for the force of mortality,
x
, is given as: 
x
x A Bc  or   where ln
x
x A Be c  
 
Where A, B, and c are empirically determined parameters which control the shape of 
the curve and x is age. The survival function which we seek is then simply defined as: 
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x
a
s dsxS exp)(  
 
Based on an age a from which lives are expected to start dying (which in our case is 
age 30), and substituting the parameters of the model we obtain the empirical 
representation of :)(xS   
 
)(
)(exp)(ˆ
xa eeB
xaAxS  
 
For a population assumed to have 100,000 people alive at aged 30, multiplying the 
equation above by 100,000 will give the number of people alive at age x, i.e. we have 
simply )(ˆ000,100 xSlx . The parameters A, B and c are estimated using an 
iterative heuristic optimisation technique of our own design.  
 
5.0 Initial results 
 
To demonstrate the suitably of the function, we initially apply the formula at two 
points in time, 1950 and 2009, using male data. These years mark the start and end 
points of our actual data and are a test of the model. Later, we split the data into ten 
year intervals from 1950 onwards and project the model to 2030.  
 
Table 3 gives the fitted values of A, B and c for 1950 and 2009 based on the procedure 
of the previous section. As B gets smaller there are fewer deaths in middle age and 
hence a fall in mortality over the period, whereas as c increases there are more deaths 
at older ages.  
 
The main contribution of A is to temper the number of deaths at younger ages after 
parameters B and c have been used to fit the majority of the ages. The advantage of a 
commencement age of 30 is that the model fits are generally extremely good since we 
do not have to contend with childhood and early adult mortality. 
 
Parameters 1950 2009 
A -0.0013798 0.0004309 
B 0.0001115 0.0000142 
c 1.0928285 1.1101324 
 0.0887693 0.1044793 
Table 3: Fitted Gompertz-Makeham parameter for 1950 and 2009 
 
Figure 6(a-d) corresponds with each component of the stylised model described in 
Section 2. Data points are based on male life tables for England and Wales in 1950 
and 2009 and fitted lines are based on the Gompertz-Makeham formula using the 
parameters in Table 3.  
 
Figure 6(a) shows the actual and fitted male survival curves at age 30 based on a radix 
of 100,000 lives. It indicates a substantial improvement in survival over the period, in 
which life expectancy at age 30 increased from 40.5 to 49.4 years. Although the 
advancement in survival bears a resemblance to the stylised model, curves are of 
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course continuous and so there is no direct correspondence with 
1x  or 2x  as previously 
explained. 
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Figure 6: Initial results showing differences in male survival and death in 1950 and 
2009 for England and Wales based on actual data and the fitted survival function 
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Figure 6(b) shows the pattern of deaths in 1950 and 2009 with a shift in modal age of 
death clearly visible, occurring at age 75 in 1950 and at age 87 in 2009 (a 12-year 
advancement over the period), also as per the stylised model. However, also evident is 
a spur of deaths at the very oldest ages in both years, although for reasons of 
simplicity this was not one of the features designed into the stylised model at the 
outset but one which could be considered in further work. 
 
Figure 6(c) shows the difference in deaths at each age over the life span. It illustrates 
the expected pattern with a postponement of death from the early to the later part of 
the age register. Clearly, the waves are not square waves as in the stylised model but 
more sinusoidal in shape although certainly not symmetrical in amplitude as would be 
indicated if survival behaved like the parallel model.  For consistency with later 
examples, we have annualised the number of deaths between snapshots by dividing 
throughout the age range by the number of elapsed years, in this case 59 years. 
 
In this example, the wave crosses the horizontal axis at age 78, which we defined 
earlier as the pivot point.  Since there is neither a double dip nor a double peak in the 
data, the regressive variants shown in Figure 3 ((d) and (e)) are clearly not applicable. 
The wave itself is asymmetric with amplitude that is less below the axis than above 
and so the parallel case is again ruled out. In the lower register there were an average 
of 24 fewer deaths per year at age 68, the bottom of the trough, and 40 more deaths 
per year at age 89 at the tip of the wave. The difference from peak to trough is 21 
years (89-68).   
 
Figure 6(d) shows the transition in deaths over the period from one assumed steady 
state to another with an annual maximum of 100,000. This is represented in the figure 
by a sudden jump from mortality rates in 1950 to those in 2009. Since we are working 
with life tables rather than actual populations, the effect may be interpreted as a 
change in mortality rates rather than a change in actual deaths over the adjustment 
period.  
 
5.1 Further analysis 
 
In this section, we wish to break down these patterns into more detail in order to 
identify any significant trends over time in the postponement of death, focussing 
especially on differences in gender.  We do so by dividing the period from 1950 to 
2030 into ten year periods, the last two of which, 2020 and 2030, are technically 
projections. As previously noted there are three issues to discuss. The first of these is 
trends in survival; the second issue are changes in the distribution in age of death 
including the mode, mean and standard deviation of age of death; and the third issue 
is death postponement. 
 
(a) Trends in survival  
 
Tables 4 and 5 show the fitted parameters for the Gompertz-Makeham formula at ten 
years intervals from 1950 to 2030 by gender.   Figure 7 shows consequential fitted 
and projected male and female survival curves in selected years, 1950, 2010 and 
2030. Female survival curves are shown in light relief and male curves in dark relief; 
hatched survival curves are projections for 2030. 
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parameters 1950 1960 1970 1980 1990 2000 2010 2020 2030 
A -0.0013798 -0.0013798 -0.0013851 -0.0009285 -0.0003608 0.0002141 0.0009000 0.0005566 0.0005487 
B 0.0001115 0.0001115 0.0001058 0.0000745 0.0000440 0.0000229 0.0000142 0.0000084 0.0000075 
C 1.0928285 1.0926881 1.092691 1.096213 1.1014624 1.107427 1.1095334 1.111649 1.1062989 
 0.0887693 0.0886408 0.0886435 0.0918615 0.0966387 0.1020393 0.1080000 0.1058445 0.1010201 
Table 4: Male parameter values for the Gompertz-Makeham formula 
 
parameters 1950 1960 1970 1980 1990 2000 2010 2020 2030 
A 0.0004751 0.000334 0.000333 0.0002456 0.0001985 0.0001861 0.0001779 0.0001552 0.0001496 
B 0.0000248 0.0000237 0.0000197 0.0000180 0.0000137 0.0000105 0.0000080 0.0000059 0.0000043 
C 1.1082509 1.1080316 1.1092629 1.1086508 1.1107354 1.1124291 1.113858 1.1148711 1.1160122 
 0.102783 0.1025851 0.1036958 0.1031437 0.1050223 0.106546 0.1078297 0.1087388 0.1097618 
Table 5: Female parameter values for the Gompertz-Makeham formula 
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As the previously identified trend in life expectancy is extrapolated through to 2030, 
the survival curves shift from left to right. Solid lines are outcomes and the hatched 
lines are projections. The projections are consistent with the trend in life expectancy 
at age 30 and with the predicted survival probabilities derived from the model based 
on the Gompertz-Makeham parameters in Tables 4 and 5. 
 
Whereas in 1950 and 2010 there are still considerable differences in male and female 
patterns of survival, projected survival curves by 2030 are more or less co-incident 
indicating almost identical survival probabilities at age 30. There are some small 
differences with the chances of male survival slightly lower than females between 
ages 50 to 75 but higher post 85.  
 
For males the improvement in life expectancy between 1950 and 2010 is roughly 
equivalent to the improvement that is projected to occur between 2010 and 2030. 
Table 6 shows that compared with 1950 the percentage of males surviving to age 70 
in 2010 increased by 23.5% (80.9% - 57.4%) as compared with 15% for females 
(86.4% - 71.4%); between 2010 and 2030 the increases are somewhat less at 8.9% 
and 5% but still faster for males.   
 
To take an older age, the percentage of males surviving to 90 increased by 17.4 % 
between 1950 and 2010 as compared with 21.3% for females; between 2010 and 2030 
the increases are projected to be 25.7% and 14.2%, so in this case there has been 
reversal with survival fortunes with males set to improve more than females at the 
oldest ages. As for living beyond 100, in 1950 the chances were negligible for either 
gender. By year 2010 they were 0.8% for males and 1.8% for females, increasing to a 
projected 4% and 3% by 2020 and then more than doubling again by 2030.  
 
 
Figure 7: Fitted male and female survival curves in 1950, 2010, and 2030 (hatched 
lines).  (Key: Males dark curves; females light curves) 
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1950 
 
2010 
 
2030 
 Predicted % 
surviving to age:  Male Female Male Female Male Female 
70 57.4 71.4 80.9 86.4 89.8 91.4 
80 23.8 39.9 56.1 65.5 76.7 77.0 
90 2.7 7.9 20.1 29.2 50.2 46.2 
95 0.35 1.4 6.8 12.2 32.5 26.4 
Life expectancy at 
30  40.7 45.2 49.7 53.0 57.1 57.1 
Table 6: Predicted survival to given ages and life expectancy at age 30, males and 
females  
 
(b) Trends in the mode, mean and standard deviation in age of death  
 
While death can occur at any age, the distribution of ages of death typically show a 
tendency to bunch in older age (see for example Figure 6(b)). A feature of the data 
over many years has been a sliding to the right of the whole distribution with 
corresponding shifts in the modal age of death (Zhang and Vaupel, 2009; Cheung and 
Robine, 2007, Kannisto, 2001).   
 
Table 7 (a) and (b) is fully consistent with this picture. It is based on three measures 
of central tendency in the age of death and two measures of dispersion:  these are the 
mode, mean and median and the standard deviation, and inter-quartile range. The 
results show that all three are steadily increasing in value over time. The predicted 
gains made by males have been higher with, for example, the male modal age of death 
advancing by 18 years between 1950 and 2030 compared with 12 years for females.  
 
The mean age of death plus or minus one standard deviation will contain 68.2% of all 
deaths post 30 years of age assuming a normal distribution; in practice the distribution 
is not exactly normal and so the actual percentage differs slightly and is higher (about 
72% of all deaths).  The trends in the mean and standard deviation of age of death are 
shown in Figure 8. The results indicate mean ages of death of males and females are 
converging and just as with life expectancy are expected to reach parity by around 
2030.  
 
The standard deviation, however, is showing a slightly contrary trend with males 
increasing slightly in value and females decreasing (both trends statistically 
significant from zero at p<0.01). This is occurring because there are a higher 
percentage of male slow improvers compared with females causing the distribution to 
bunch less plus more very old males in later projections. This is also reflected in 
changes to the inter-quartile range (IQR), the age range in which 50% of all deaths 
occur. As the Table 7 demonstrates this range tends to be slightly lower for females 
than for males again indicating a greater bunching in female deaths.     
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(a) Males 
year mode mean 
standard 
deviation median IQR 
1950 75 70.4 11.9 71 17 
1960 75 70.5 11.9 71 16 
1970 76 71.1 11.9 72 16 
1980 77 72.3 11.9 73 16 
1990 79 74.0 12.0 75 16 
2000 82 76.2 12.2 78 15 
2010 85 79.2 12.5 81 16 
2020 89 82.6 12.8 84 15 
2030 93 87.0 13.5 89 16 
 
(b) Females 
     
year mode mean 
standard 
deviation median IQR 
1950 80 74.7 12.3 76 16 
1960 81 75.4 12.2 77 16 
1970 82 76.4 12.2 78 16 
1980 83 77.7 12.2 79 15 
1990 85 79.1 12.1 81 15 
2000 86 80.6 12.0 82 15 
2010 88 82.1 11.9 84 15 
2020 90 84.3 11.9 86 14 
2030 92 86.5 11.9 88 15 
Table 7(a) and (b): Modal age of death, mean and standard deviation, median and 
inter-quartile range (IQR) for each year by gender  
 
 
Figure 8: Male and female trends in the mean and standard deviation in the age of 
death 
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(c) Trends in the postponement of death 
 
Figures 9 and 10 show the differences in the average annual number of deaths 
between males and females between successive decades. Axes are drawn on a similar 
scale to facilitate gender comparisons based on the pattern of evolution in the 
resulting waves. Since the population is constrained to 100,000 at age 30, deaths 
below the axis equal deaths above.  
 
Visually the results show that the waves are trending higher up the age register and at 
the same time are increasing in amplitude both above and below the axis. In later 
periods, the waves below the axis trend closer to zero as there are fewer lives to save 
and therefore deaths to postpone. These patterns are consistent with an accelerating 
shift in deaths to older ages.  
 
The increase in the amplitude of the waves for males is far more striking than for 
females and is a reflection of previously identified trends in the data. To better 
understand these trends, we defined the following eight indictors:  
 
A. Trough   - age at the lowest point in wave 
B. Peak     - age at the highest part of wave 
C. Trough to peak age range - B minus A (years) 
D. Pivot age   - age at which difference in deaths is zero 
E. Pivot to peak  - B minus D (years) 
F. Trough to pivot  - D minus A (years) 
G. Amplitude below zero - difference in deaths at trough age 
H. Amplitude at peak  - difference in deaths at peak age 
 
The results are shown in Tables 8 and 9 and the first six of the indicators are 
represented graphically in Figure 11(A-F). 
 
 
Figure 9: Changes in male deaths by age in ten periods from 1950 to 2030  
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Figure 10: Changes in male deaths by age in  eight  ten-year periods from 1950 to 
2030  
 
The trough age is the age at which deaths have fallen most between two points in time 
and therefore where the greatest improvement in survival has resulted. The age when 
the male trough occurs has increased from age 66 between 1950 and 1960 and is 
expected to reach 83 between 2020 and 2030. Based on Figure 11(A) the male trough 
will surpass the female trough between 2020 and 2030 again emphasising the rapidity 
in male gains. 
 
The peak represents the age at which the difference in deaths compared with a 
previous point in time are greatest. Based on Figure 11(B) the male peak will surpass 
the female peak, in terms of age when the peak is reached, between 2010 and 2020. 
The smaller the age difference between trough and peak, the more death is being 
postponed over a shorter age range. The effect observed is as a result of compression, 
as the middle percentiles of the survival distribution catch up with the subsequent 
percentiles. The net result, shown in Figure 11(C), is that gains in life expectancy are 
tending to occur at increasingly older ages with successive waves to the right of the 
age register.  
 
The advancement of pivot age is another way of measuring postponement. Pivot age 
denotes the age at which deaths turn from being lower than at the same age at a 
previous point in time to becoming higher.  Results show that male pivot age 
increased just two years from 77 to 79 years prior to 2000, but then jumped to 83 
years between 2000 and 2010 and is expected to increase again to 92 years between 
2020 and 2030. As Figure 11(D) shows, male and female pivot ages will converge 
between 2020 and 2030. 
 
The reduction in the years between pivot and peak indicates a compaction of deaths 
into a narrower age range between two points in time. Figure 11(E) shows that 
initially female deaths are more compacted than for males. The indictor is more 
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erratic than some of the previous indicators but again it shows that convergence will 
occur between 2020 and 2030.   
 
Differences in wave amplitudes are also indicative of the pattern of postponement, for 
example if death is being postponed from a wider range of ages below the line to a 
narrower range of ages above the line. Tables 8 and 9 rows G and H indicate that this 
applies here with the amplitude below the line being consistently less than the 
amplitude above.  
 
As suggested by the stylised model (see Figure 3), this pattern would be consistent 
with
'
1x , the age of onset of mortality, increasing by more than age 
'
2x , the maximum 
age of death and so the net effect can be conceptualised as a combination of the 
compression and parallel cases. That is the onset of death is being postponed by more 
than the advancement in maximum age with greater compaction of death being the net 
outcome. 
 
As well as comparing each gender at different points in time we can also compare 
both genders at the same point in time. Figure 12 shows that there were more male 
deaths relative to women before the age of 76 in 1950 and before age 85 in 2010. An 
interesting implication of this pattern is that between 2020 and 2030 there will be a 
double peak of male deaths, albeit not very pronounced (see Figure 3 case 4, stylised 
model regressive case (i)). Before age 67, there will be slightly more male than female 
deaths; between ages 67 and 97 more female deaths; and post 97 more female deaths. 
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row age 
1960-
1950 
1970-
1960 
1980-
1970 
1990-
1980 
2000-
1990 
2010-
2000 
2020-
2010 
2030-
2020 
A trough (age) 66 65 63 66 69 74 77 83 
B peak (age) 87 86 85 87 89 93 96 101 
C peak to trough (years) (B-A) 21 21 22 21 20 19 19 18 
D pivot age (P) 77 75 75 77 79 83 87 92 
E pivot to peak (years) (B-D) 10 11 10 10 10 10 9 9 
F pivot to trough (years) (D-A) 11 10 12 11 10 9 10 9 
G -ve amplitude (difference in deaths per year) 2 8 21 30 42 54 62 86 
H +ve amplitude (difference in deaths per year) 3 16 48 51 71 98 115 154 
Table 8: Values of the eight specified indicators for males 
 
 
row age 
1960-
1950 
1970-
1960 
1980-
1970 
1990-
1980 
2000-
1990 
2010-
2000 
2020-
2010 
2030-
2020 
A trough (age) 71 71 74 73 75 77 79 81 
B peak (age) 90 90 92 92 94 93 95 99 
C peak to trough (years) (B-A) 19 19 18 19 19 16 16 18 
D pivot age (P) 80 81 83 82 84 86 88 90 
E pivot to peak (years) (B-D) 10 9 9 10 10 7 7 9 
F pivot to trough (years) (D-A) 9 10 9 9 9 9 9 9 
G -ve amplitude (difference in deaths per year) 9.9 15.9 21.9 20.1 25 26.8 38.8 40.61 
H +ve amplitude (difference in deaths per year) 21.3 30.7 43.0 40.0 48.7 51.9 74.9 78.0 
Table 9: Values of the eight specified indicators for females 
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Figure 11: Convergence indicators males 
and females 
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Figure 12: Difference in number of deaths by age in 1950, 2010 and 2030. 
 
6.0 Conclusions 
 
This paper has compared trends in male and female life expectancy in England and 
Wales. It deliberately focussed on people at age 30 rather than birth in order to 
remove biologically related differences in survival in the first years of life and higher 
deaths record by males from accident, suicides, etc. in the their early adult years. 
 
The results show a well entrenched trend with male life expectancy improving more 
quickly than females in the most recent periods.  The gap was at its greatest in 1970 at 
5.7 years but fell to 3.7 years in 2009, and based on current trends may converge with 
a future life expectancy of 57 years in 2030. It was argued that most of the differences 
in life expectancy were due to societal factors and not to fundamental biological 
differences. 
 
A stylised survival model was developed to show how improved survival prospects 
were being transmitted through the age range with death being postponed from 
younger to older ages.  Based on data from 1950 to 2009, this yielded the following 
findings: 
 
  Improvements in survival are occurring at most ages for both genders in line 
with general increases in life expectancy at age 30.  In terms of the stylised 
survival model, visually the pattern of improvement most closely resembled 
the parallel case and so rectangularistion is ruled out; however, the pattern is 
not clear cut and elements of divergent and convergent behaviour are clearly 
present especially in the upper and lower age registers. We found weak 
convergence in 94% of the age range in females and 68% in males. 
  
 More detailed analysis finds that males that were expected to die between ages 
65 to 89 and females aged 50 to 89 had experienced faster than average 
improvements in survival than the general population. In contrast to the 
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beginning of the period, projected survival chances at the oldest ages favoured 
males.  In 1950 a male had a 0.35% chance of reaching 95 years but by 2030 
this could increase to 32.5%. By comparison the female chances were 1.4% 
and 26.4% respectively.   
 
 As life expectancy has increased, so the modal and mean age of death has also 
advanced. However, as is consistent with the parallel stylised model variant, 
the proportion of deaths around the modal age and the standard deviation of 
age of death have remained broadly similar even though the mean and modal 
ages of death have shifted to the right. When these trends are projected 
forward to 2030 the mean ages of death merge. Although the standard 
deviations of age at death are similar, male standard deviation is increasing 
and female decreasing. 
 
 A change to pivot age which is an indicator of by how much death has been 
postponed between successive decades also shows a continuous pattern of 
upward movement. A low pivot age indicates postponement is occurring at 
younger ages and a high pivot age at older ages. In the decades 1950-1960, 
2000-2010, 2020-2030, male pivot age increases from 77 to 83 and then to 92. 
The equivalent results for females were 80 to 86 to 90, suggesting therefore 
that male pivot age is set to surpass female pivot age between 2020 and 2030. 
 
 
The trend towards convergence in males and female life expectancy in England and 
Wales was not uniformly reflected in our comparator countries France, Japan and 
Sweden. In Japan, we found that the gender difference in life expectancy is diverging, 
while in France convergence is proceeding but at a much slower pace. In Sweden, by 
contrast convergence is projected to occur earlier than in England and Wales.   
 
In considering why convergence was occurring and why deaths in males were being 
postponed at a faster rate than in females, smoking prevalence was identified as a key 
factor. Using WHO data from 37 countries, it was found that gender differences in 
smoking prevalence explained 75% of the gap in life expectancy in the countries 
concerned. These results are therefore similar to Pampel’s findings (e.g. Pampel, 
2002) and are key to understanding gender differences in life expectancy.  
 
A more detailed examination of trends in life expectancy from the beginning of the 
last century demonstrated a clear pattern in smoking behaviour between genders and 
consequent life expectancy. In Sweden, where males historically smoked the least, 
there was almost gender parity in life expectancy at age 30 in 1922 following decades 
of reduction in the gap. The divergence in life expectancy that followed over the next 
50 years can be traced to smoking but was never as great as that seen in other 
countries.  
 
In England at Wales, male and female smoking prevalence is just over 20% and 
therefore already low versus comparator countries. This compares with male smoking 
prevalence of any form of tobacco of 82% in 1948.  Other factors that have 
contributed to improvements in male life expectancy are de-industrialisation and the 
virtual disappearance of hazardous industry such as deep coal mining.  There have 
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also been significant improvements in the treatment of heart disease which tended to 
affect males more than females (primarily the result of smoking). 
 
For convergence in male-female life expectancy to occur in practice, our projections 
show that the gap still needs to reduce by another 3.7 years. These years could come 
from several sources and are likely to come from the differential impact of gender 
specific factors rather than general improvements.  For males, it is clear that there will 
be further improvements as lapsed and heavy smokers die out along with former 
workers in hazardous industries. A possible hindering factor will be the stubborn and 
deep rooted socio-economic differences in life expectancy which, as was seen, 
affected males more than females.  
 
On the female side, the emancipation of women may have led to life expectancy 
improving at a slower rate. This is believed to be due in part to the adoption of some 
male habits such as alcohol consumption above recommended limits and the slower 
decline in smoking prevalence, albeit from a lower base.  In addition, surveys show 
that obesity is more prevalent in women than in men although men are slightly more 
prone to being categorised as ‘overweight’ as opposed to ‘obese’. Obesity negatively 
impacts on life expectancy, especially with the most obese males and females 
potentially losing 10 years or more from their future life span lives at age 30 were 
they to remain obese.  
 
The combined effect of these trends to date is that male death patterns are becoming 
increasingly similar to female death patterns over a large part of the age range. This is 
manifesting in a progressively right shift in the mean and modal age of death at ages 
in people’s mid 80s. At the oldest ages male survival may actually be slightly higher 
in future, and at younger ages the reverse is true with females having better survival 
prospects.   
 
In conclusion, there has been a remarkable improvement in male life expectancy since 
1970 relative to women. Although women remain ahead, the gap is reducing quickly 
so that if it continues there will be parity by 2030. This trend is almost certainly the 
result of changes in male and female lifestyles and not to genetic or biological factors. 
We can be fairly sure of this otherwise there would be a much greater similarity 
between countries than is actually the case, whereas many of the differences can be 
explained in most part simply by differences in smoking prevalence.  
 
This finding concurs with the work of Preston and Wang (2006) who demonstrate that 
mortality differences between males and females is consistent with differences in the 
prevalence of cigarette smoking by individual cohorts. With recent changes in 
smoking patterns, their model suggests that sex differences in mortality will narrow 
dramatically in coming decades. Thus, we conclude that the prospects for both 
convergence and increases in life expectancy are tied closely with future reductions in 
tobacco consumption. 
 
The social consequences of increased longevity and convergence in life expectancy 
will continue to be felt throughout society in public services and pensions and so 
reforms to both will be both a necessity and inevitable outcome of these trends.  
Convergence will make it easier for insurers to set unisex annuity rates and help make 
more sense of sex equality legislation when it comes to pension age. For individual 
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citizens the effect can be mitigated however if people are able to remain in good 
health, and live and work independently for longer.  
 
As the survival frontier (Kannisto, 1996) extends farther outwards however, public 
reforms will need to refocus on a burgeoning numbers of people with social as well as 
health care needs and hence a reorientation of spending priorities towards long term 
management of conditions of old age. The converging of male and female life 
expectancy may be a help rather than a hindrance in this respect, especially if it leads 
to fewer women living alone and in isolation for the last few years of their lives.    
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Annex A:  Stylised model survival including equations and 
parameters of interest 
 
Imagine a stationary population in which there is a constant number of births and 
deaths, no migration and which is subjected to the same mortality regime each year. 
Consider Figures A1 (a) – (c), which show the mortality curves ABC for three such 
hypothetical populations at a given point in time.  
 
The vertical axis shows the number of survivors lx and the horizontal axis age x. We 
define the point 
1x  in each case as the onset of mortality, the age at which death 
begins, which can range from zero upwards. For simplicity we assume there are no 
deaths before this age. We call the point where BC cuts the age axis as 
2x  or the 
maximum age to which anyone lives.  
 
The figures to the right of each variant ar a plot of the percentage of population 
surviving to a given age versus life expectancy at age
1x .   Each variant generates a 
distinctive pattern for example the percentile in the convergent model meet at a point 
which is the maxim age or
2x . We use these hypothetical patterns to search for similar 
patterns in the data. Table A1 sets out various demographic parameters of interest 
based on each of the cases. 
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Figure A1: Three simplified survival variants: (a) divergent, (b) parallel and (c) 
convergent 
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at each year of age 
where death is 
possible 
1
2 1
xl
x x
 
 
1
2 1
xl
x x
 1
2 1
xl
x x
 
4 Coefficient of 
rectangularisation 
2 1
22
x x
x
 2 1
22
x x
x
 2 1
22
x x
x
 
5 Proportion of 
population 
deceased as a 
function of 
1x
e  and 
age x  
 
1
1
2 x
x x
p x
e
 
 
1
1
1 12 x
x x
p x
e x x
 
 
1
1
1 12 x
x x
p x
e x x
 
6 Survival function 
as a function of 
1x
e   
1
11
2 x
x x
e
 
1
1
1 1
1
2 x
x x
e x x
 
1
1
1 1
1
2 x
x x
e x x
 
7 Force of Mortality 
at age x  
1 1
1
2 xe x x
 
1 1 1 1
1
2 xe x x x x
 
1 1 1 1
1
2 xe x x x x
 
8 Inter percentile 
range, x  
1
2 xe p x  )()(2
'
111
xpxxex  
12 1
2 xx x e p x  
9 Deaths avoided or 
person years saved  
1
2 2
2
xl
x x  1 2 2x
l x x  1
1 1
2
xl
x x  
10 Adjustment cycle 
(years) 
2 1x x  
 
2 1x x  2 1x x  
11 Mean age of  
Population, x  
1 2 1 2
1 23 3
x x x x
x x
 
1 2 1 2
1 23 3
x x x x
x x
 1 2 1 2
1 23 3
x x x x
x x
 
12 Median age 
1 2
1
4
x x  1 2
1
4
x x  1 2
1
4
x x  
Table A1: Some parameters of interest 
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Annex B: Smoking prevalence and gender gap in life expectancy 
 
Figure B1 is a cross-sectional plot of differences in male female life expectancy at age 
30 against the difference in smoking prevalence between males and females for 37 
developed countries covered by the Human Mortality Database (sources: HMD and 
World Health Organisation Tobacco Free Initiative, 2011
6
). A regression analysis 
showed that differences in smoking prevalence statistically explain 75% of the 
variation in the gap in life expectancy at age 30. 
 
 
Figure B1: Cross-section plot of the difference in life expectancy at age 30 between 
males and females versus the prevalence gap in smoking for 37 countries 
 
 
 
                                                 
6
 http://www.mortality.org/; http://www.who.int/tobacco/global_report/2011/en/ 
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